Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, June 24 at 2:00 PM EDT

Register Free →

Government Contract

Active
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The contract forecast pertains to the Indian Health Service and focuses on activities related to the flu, classified under the NAICS code 325414, which corresponds to pharmaceutical preparation manufacturing. Although specific contract details such as title, solicitation number, and location are not provided, the forecast indicates forthcoming opportunities relevant to flu-related services or products. The document was posted on March 11, 2026, and is intended to inform potential vendors or stakeholders about anticipated contracting needs. Important contacts for this forecast include Aaron Cardenaz, serving as the Program Point of Contact, and Sean Long, the Contracting Officer, who can provide additional information or clarification. The forecast does not specify any set-aside type or targeted business classification, suggesting a general competitive opportunity. Interested parties are directed to the Indian Health Service through the provided contact emails or the industry opportunity forecast portal to monitor updates and engage in potential contracting processes.

General Info

Indian Health Service forecast for flu-related pharmaceutical manufacturing contracts, posted March 2026.

Agency

Indian Health Service

NAICS

325414 - Biological Product (except Diagnostic) Manufacturing View NAICS

Place of Performance

US

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

Posted

forecast

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyIndian Health Service
Contacts2 people available
OfficeN/A
Organization / Agency
Indian Health Service
Office AddressN/A
Contacts
Aaron Cardenaz
Sean LongContracting Officer

Full Description

Show more
Flu

Similar Contracts

NAICS: 325414
New
Federal
iNDI FA13.1J Cell Lines Expansion and Distribution for the iPSC Neurodegenerative Disease Initiative (iNDI) ProjectThe Department of Health and Human Services, through the National Institutes of Health's National Institute on Aging, intends to award a sole source contract to The Jackson Laboratory for the expansion, quality control, biobanking, and distribution of isogenic Alzheimer’s disease and related dementias induced pluripotent stem cell lines as part of the iPSC Neurodegenerative Disease Initiative (iNDI) Project. This contract will focus on providing up to 936 specific iPSC lines, including 486 FA13.1J female SNV lines and 450 lines across 25 high-priority SNV trios, adhering to iNDI protocols for quality and expansion. The Jackson Laboratory is uniquely qualified for this contract as it currently houses the existing distribution infrastructure and has demonstrated successful past performance in supporting NIH’s iNDI requirements. The contract is planned to be a firm-fixed-price agreement with a performance period starting September 1, 2026, for a base year and up to three option years, ending August 31, 2030. The primary place of performance will be the contractor’s facility in Bar Harbor, Maine. While this notice signals the intent for a sole source award, other capable sources may submit capability statements demonstrating their ability to meet the outlined requirements, including supply of the specific cell lines, adherence to quality protocols, product and web content creation, and public distribution via an established platform. Responses must be submitted electronically by June 23, 2026, and the Government reserves the right to consider all responses but is under no obligation to initiate a competitive procurement.
National Institutes Of Health Olao

POSTED

about 18 hours ago

DEADLINE

in 12 days
View Details